Disseminated seminoma: Re-evaluation of treatment protocols

W. L. Mendenhall, S. D. Williams, Lawrence Einhorn, J. P. Donohue

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Radiotherapy provides a high cure rate for patients with stages I and II seminoma but the results for those with stage III disease have been disappointing. We report on 19 patients with high stage seminoma who have been treated with platinum, vinblastine and bleomycin (14 patients) or platninum, vinblastine, bleomycin and doxorubincin hydrochloride (5 patients). Of the 19 patients 12 (63 per cent) had complete remission of the disease and the remaining 7 had partial remission. To date, 11 patients (58 per cent) remain free of disease. Of the 6 patients with no prior irradiation 5 achieved complete remission, while the 1 failure had massive hepatic metastases. The median followup was 19 months (range 12 to 37 months). These results parallel that achieved with the same chemotherapy regimen in patients with stage III nonseminomatous testicular cancer.

Original languageEnglish
Pages (from-to)493-496
Number of pages4
JournalJournal of Urology
Volume126
Issue number4
StatePublished - 1981

Fingerprint

Seminoma
Clinical Protocols
Vinblastine
Bleomycin
Testicular Neoplasms
Platinum
Radiotherapy
Neoplasm Metastasis
Drug Therapy
Liver

ASJC Scopus subject areas

  • Urology

Cite this

Mendenhall, W. L., Williams, S. D., Einhorn, L., & Donohue, J. P. (1981). Disseminated seminoma: Re-evaluation of treatment protocols. Journal of Urology, 126(4), 493-496.

Disseminated seminoma : Re-evaluation of treatment protocols. / Mendenhall, W. L.; Williams, S. D.; Einhorn, Lawrence; Donohue, J. P.

In: Journal of Urology, Vol. 126, No. 4, 1981, p. 493-496.

Research output: Contribution to journalArticle

Mendenhall, WL, Williams, SD, Einhorn, L & Donohue, JP 1981, 'Disseminated seminoma: Re-evaluation of treatment protocols', Journal of Urology, vol. 126, no. 4, pp. 493-496.
Mendenhall WL, Williams SD, Einhorn L, Donohue JP. Disseminated seminoma: Re-evaluation of treatment protocols. Journal of Urology. 1981;126(4):493-496.
Mendenhall, W. L. ; Williams, S. D. ; Einhorn, Lawrence ; Donohue, J. P. / Disseminated seminoma : Re-evaluation of treatment protocols. In: Journal of Urology. 1981 ; Vol. 126, No. 4. pp. 493-496.
@article{b63547fd50fa4e6583f015930035e0c9,
title = "Disseminated seminoma: Re-evaluation of treatment protocols",
abstract = "Radiotherapy provides a high cure rate for patients with stages I and II seminoma but the results for those with stage III disease have been disappointing. We report on 19 patients with high stage seminoma who have been treated with platinum, vinblastine and bleomycin (14 patients) or platninum, vinblastine, bleomycin and doxorubincin hydrochloride (5 patients). Of the 19 patients 12 (63 per cent) had complete remission of the disease and the remaining 7 had partial remission. To date, 11 patients (58 per cent) remain free of disease. Of the 6 patients with no prior irradiation 5 achieved complete remission, while the 1 failure had massive hepatic metastases. The median followup was 19 months (range 12 to 37 months). These results parallel that achieved with the same chemotherapy regimen in patients with stage III nonseminomatous testicular cancer.",
author = "Mendenhall, {W. L.} and Williams, {S. D.} and Lawrence Einhorn and Donohue, {J. P.}",
year = "1981",
language = "English",
volume = "126",
pages = "493--496",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Disseminated seminoma

T2 - Re-evaluation of treatment protocols

AU - Mendenhall, W. L.

AU - Williams, S. D.

AU - Einhorn, Lawrence

AU - Donohue, J. P.

PY - 1981

Y1 - 1981

N2 - Radiotherapy provides a high cure rate for patients with stages I and II seminoma but the results for those with stage III disease have been disappointing. We report on 19 patients with high stage seminoma who have been treated with platinum, vinblastine and bleomycin (14 patients) or platninum, vinblastine, bleomycin and doxorubincin hydrochloride (5 patients). Of the 19 patients 12 (63 per cent) had complete remission of the disease and the remaining 7 had partial remission. To date, 11 patients (58 per cent) remain free of disease. Of the 6 patients with no prior irradiation 5 achieved complete remission, while the 1 failure had massive hepatic metastases. The median followup was 19 months (range 12 to 37 months). These results parallel that achieved with the same chemotherapy regimen in patients with stage III nonseminomatous testicular cancer.

AB - Radiotherapy provides a high cure rate for patients with stages I and II seminoma but the results for those with stage III disease have been disappointing. We report on 19 patients with high stage seminoma who have been treated with platinum, vinblastine and bleomycin (14 patients) or platninum, vinblastine, bleomycin and doxorubincin hydrochloride (5 patients). Of the 19 patients 12 (63 per cent) had complete remission of the disease and the remaining 7 had partial remission. To date, 11 patients (58 per cent) remain free of disease. Of the 6 patients with no prior irradiation 5 achieved complete remission, while the 1 failure had massive hepatic metastases. The median followup was 19 months (range 12 to 37 months). These results parallel that achieved with the same chemotherapy regimen in patients with stage III nonseminomatous testicular cancer.

UR - http://www.scopus.com/inward/record.url?scp=0019403824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019403824&partnerID=8YFLogxK

M3 - Article

C2 - 6169850

AN - SCOPUS:0019403824

VL - 126

SP - 493

EP - 496

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -